About: http://webisa.webdatacommons.org/90834051

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Resverlogix initiated a research program dedicated to ApoA-I production and testing its therapeutic potential for disorders that affect cognitive function, such as Alzheimer's Disease.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com